肉苁蓉苷A通过JNK/MAPK通路抑制破骨细胞活性  

Cistanoside A mediates p38/MAPK pathway to inhibit osteoclast activity

作　　者：李岳尧 张民[2] 杨家驹 Li Yueyao;Zhang Min;Yang Jiaju(Shanxi University of Chinese Medicine,Jinzhong 030619,Shanxi Province,China;Second Hospital of Shanxi University,Taiyuan 030001,Shanxi Province,China)

机构地区：[1]山西中医药大学,山西省晋中市030619 [2]山西医科大学第二医院,山西省太原市030001

出　　处：《中国组织工程研究》2025年第6期1144-1151,共8页Chinese Journal of Tissue Engineering Research

基　　金：山西省中医药管理局省中医药科研课题,项目负责人:张民。

摘　　要：背景:研究证实肉苁蓉苷A具有抗炎、抗氧化和抗骨质疏松的作用,但其对破骨细胞分化和功能的影响及潜在的机制尚缺少研究。目的:探讨肉苁蓉苷A对核因子κB受体活化因子配体诱导的体外破骨细胞分化和骨吸收功能的影响及作用机制。方法:提取与培养4-6周龄C57BL/6小鼠股骨和胫骨中的骨髓巨噬细胞,采用CCK-8毒性实验检验不同浓度的肉苁蓉苷A(5,10,20,40,80,160μmol/L)对骨髓巨噬细胞的毒性,抗酒石酸酸性磷酸酶染色观察不同浓度的肉苁蓉苷A干预破骨细胞的分化情况,确定药物的有效干预浓度。将实验分为阳性对照组、肉苁蓉苷A低、中、高剂量组(40,80,160μmol/L),细胞贴壁后各组均加入50 ng/mL的核因子κB受体活化因子配体诱导破骨细胞分化,肉苁蓉苷A低、中、高剂量组分别加入相应剂量的肉苁蓉苷A进行干预。采用肌动蛋白环鬼笔环肽染色和DAPI染色检测肉苁蓉苷A对破骨细胞形成的影响;骨磨片甲苯胺蓝染色观察肉苁蓉苷A对破骨细胞骨吸收功能的影响;Western blot检测JNK/MAPK通路上下游蛋白的表达情况;RT-qPCR检测抗酒石酸酸性磷酸酶、DC-STAMP、Nfatc-1、Ctsk和c-Fos等破骨细胞分化和骨吸收功能相关基因的表达情况。结果与结论:①抗酒石酸酸性磷酸酶染色、肌动蛋白环染色和骨陷窝甲苯胺蓝染色结果表明,与阳性对照组相比,肉苁蓉苷A对核因子κB受体活化因子配体诱导的体外破骨细胞的分化和骨吸收功能具有呈剂量依赖性的显著抑制作用;②RT-qPCR结果表明,与阳性对照组相比,肉苁蓉苷A高剂量组和低剂量组的抗酒石酸酸性磷酸酶、DC-STAMP、Nfatc-1、Ctsk和c-Fos等的mRNA表达量均显著降低,且肉苁蓉苷A高剂量组的降低效果更加显著;③Western blot结果显示,高剂量肉苁蓉苷A干预10,20,30和60 min时显著抑制p-JNK蛋白的表达;与阳性对照组相比,肉苁蓉苷A低、中、高剂量组显著抑制NfBACKGROUND:Cistanoside A has the effects of anti-inflammation,antioxidation,antioxidation,reducing renal damage and anti-osteoporosis,but its effect on osteoclast differentiation,function and its underlying molecular mechanisms remain unclear.OBJECTIVE:To investigate the effect of Cistanoside A on osteoclast differentiation and bone resorption induced by receptor activator of nuclear factor kappa-B ligand(RANKL)in vitro and its mechanism.METHODS:Bone marrow macrophages were obtained from the femur and tibia of 4-6-week-old C57BL/6 mice.The cytotoxic effect of Cistanoside A(5,10,20,40,80,and 160μmol/L)on bone marrow macrophage viability was examined using the cell counting kit-8 assay kit.Tartrate-resistant acid phosphatase staining was performed to observe the effect of different concentrations of Cistanoside A on osteoblast differentiation and its effective intervention concentration was determined.There was positive control group,Cistanoside A low,medium,and high dose groups(40,80,and 160μmol/L).After cell attachment,50 ng/mL RANKL was added to induce osteoblast differentiation,and the corresponding dose of Cistanoside A was added to the Cistanoside A low,medium,and high dose groups,respectively.F-actin ring and 2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride staining were performed to detect the effects of Cistanoside A on the formation of osteoclasts.Toluidine blue staining of bone abrasion slices was used to observe the effects of Cistanoside A on bone resorption function of osteoclasts.The expression of upstream and downstream proteins of the JNK/MAPK pathway was detected by Western blot.The expression of genes related to osteoclast differentiation and bone resorption function such as tartrate-resistant acid phosphatase,DC-STAMP,Nfatc-1,Ctsk and c-Fos was detected by RTqPCR.RESULTS AND CONCLUSION:Tartrate-resistant acid phosphatase staining,F-actin ring staining and resorption pit assay showed that Cistanoside A significantly inhibited RANKL-induced osteoclast differentiation and bone resorption i

关 键 词：肉苁蓉苷A 破骨细胞 MAPK JNK RANKL RANK 骨质疏松 苯乙醇苷 

分 类 号：R496[医药卫生—康复医学] R318[医药卫生—临床医学] R446